沙利卢马布用于治疗低临床活性得分的格雷夫斯轨道病变
José Pérez-Moreiras1, Dolores Abelenda1, Joana Providência2,3
1Centro Oftalmologico Moreiras, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Scientific reports
|January 14, 2026
概括
沙利卢马布有效地治疗了低疾病活性患者的Graves轨道病变 (GO),显著改善了临床得分和生活质量. 治疗表明了良好的安全性,没有观察到任何重大不良事件.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 格雷夫斯轨道病 (GO) 显著影响生活质量,特别是在临床活动较低的患者中.
- 目前用于低活性GO的治疗方法可能无法完全解决患者报告的结果.
研究的目的:
- 评估沙利卢马布在治疗Graves轨道病患者的疗效和安全性,其临床活性得分较低 (CAS 1-3).
- 评估沙利卢马布对临床活性的影响,甲状腺刺激性免疫球蛋白 (TSI) 水平和生活质量 (GO-QOL).
主要方法:
- 对62名GO患者进行了回顾性纵向研究,这些患者接受了沙利卢马布治疗 (150mg或200mg皮下注射).
- 在2019年1月至2024年1月期间收集的数据.
- 主要结果:降低CAS和STI水平;次要结果:改善GO-QOL分数.
主要成果:
- 平均CAS显著减少,从2.22降至0.05.
- 平均STI水平从38.70U/L大幅下降到10.53U/L.
- 平均GO-QOL得分从64.72%大幅提高到96.38%.
结论:
- 沙利卢马布是低临床活性格雷夫斯轨道病患者的有效治疗方法.
- 沙利卢马布表现出良好的安全性,没有报告重大不良事件.
- 这些发现支持sarilumab作为一种可行的治疗选择,用于改善GO患者的治疗结果和生活质量.
相关概念视频
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
Gastritis III: Clinical Manifestations and Management
1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K


